Identification and validation of RIPK3 as a novel biomarker to predict outcomes in patients with acutely decompensated cirrhosis
{{output}}
Background: In cirrhosis patients with acute decompensation (AD) and acute-on-chronic liver failure (ACLF) non-apoptotic forms of cell death predominate with increasing severity, which are potential targets of therapy. This study... ...
